NorthRock Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249K Sell
1,121
-404
-26% -$93.9K ﹤0.01% 608
2026
Q2
$362K Buy
1,525
+17
+1% +$3.53K 0.01% 492
2026
Q1
$319K Buy
+1,508
New +$325K 0.01% 505
2025
Q4
– Sell
-2,631
Closed -$413K – 667
2025
Q3
$413K Sell
2,631
-5,174
-66% -$799K 0.01% 592
2025
Q2
$1.31M Sell
7,805
-1,046
-12% -$155K 0.03% 194
2025
Q1
$1.22M Sell
8,851
-109,428
-93% -$13.9M 0.04% 180
2024
Q4
$14M Sell
118,279
-322
-0.3% -$37.6K 0.46% 32
2024
Q3
$13.1M Buy
118,601
+35,134
+42% +$3.67M 0.43% 33
2024
Q2
$8.21M Sell
83,467
-33
-0% -$3.36K 0.31% 43
2024
Q1
$9.34M Sell
83,500
-4,312
-5% -$465K 0.36% 42
2023
Q4
$8.85M Buy
+87,812
New +$8.71M 0.37% 39

Other funds holding CAH

NorthRock Partners's CAH Position: Q3 2026 in Review

NorthRock Partners reduced its Cardinal Health (CAH) stake by 26% in Q3 2026, selling an estimated $93.9K and leaving 1,121 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

NorthRock Partners first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. The position peaked at $14M in Q4 2024. 1,490 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • NorthRock Partners held 1,121 shares of Cardinal Health worth $249K as of Q3 2026.
  • NorthRock Partners sold 404 Cardinal Health shares in Q3 2026, an estimated $93.9K.
  • Cardinal Health made up ﹤0.01% of NorthRock Partners's portfolio in Q3 2026, its #608 holding.
  • NorthRock Partners first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • NorthRock Partners's Cardinal Health position peaked at $14M in Q4 2024.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on NorthRock Partners's 13F filing for Q3 2026, filed 13 Nov 2026.